Ann Noninvasive Electrocardiol 2022 Jun 17:e12977. Epub 2022 Jun 17.
The Third Departments of the First Affiliated Hospital of Xinjiang Medical University, Urumuqi, China.
Objective: To analyze the efficacy and safety of antiplatelet drugs combined with new oral anticoagulants (noac) in the treatment of coronary atherosclerotic heart disease (CAD).
Methods: The randomized controlled trials of noac combined with antiplatelet therapy in Cochrane, CNKI, PubMed, EMBASE, Wanfang, Google Scholar, and Baidu library were searched using the literature database. Two researchers independently searched and screened to ensure the consistency of the results, and the literature was summarized and analyzed by Revman 5. Read More